from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0754/PE_PGRS11

LFCtreatmentdescriptionclass of inhibitor

-1.011

Amikacinug/mL Amikacintranslation

-0.325

Cap5-10ug/mL Capreomycintranslation

-0.297

Rox10-50 ug/mL Roxithromycintranslation

-0.569

SM2-5 ug/mL Streptomycintranslation

-1.121

Tet5-10 ug/mL Tetracyclinetranslation

-1.065

Rif0.2-5ug/mL Rifampicintranscription

-1.021

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.076

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.650

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.041

CPZ10-50 ug/mL Chlorpromazinerespiration

0.258

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.281

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

3.793

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

4.032

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.225

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.188

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.049

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.211

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.824

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.079

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

3.106

KCN5-20 ug/mL Potassium cyaniderespiration

-0.305

NaN30.2-2 mM Sodium aziderespiration

-0.173

Nigericin50 uM Nigericinrespiration

0.243

TRC10-150 ug/mL Triclosanrespiration

0.883

TRZ10-25 ug/mL Thioridazinerespiration

1.045

Valinomycin0.5-10 uM Valinomycinrespiration

-1.007

ZnSO42 mM ZnSO4respiration

-0.307

menadione6-10 ug/mL Menadionerespiration

0.152

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.472

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.069

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.278

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.093

NRP_1Non-replicating persistence stage 1dosRassociated

-0.892

Amp0.2mg/mL AmpicillincellWall

-0.231

Cephalexin20-100 ug/mL CephalexincellWall

-0.179

Cerulenin0.32-5 ug/mL CerulenincellWall

-1.609

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.867

EMB10-20 ug/mL EthambutolcellWall

-0.793

Eta12-40 ug/mL EthionamidecellWall

-0.858

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.759

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.115

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.505

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.455

BZA0.12 mg/mL BenzamidearomaticAmides

0.094

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.449

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.097

H2O24 mM hydrogen peroxideDNAdamaging

-0.028

Levo10 ug/mL LevofloxacinDNAdamaging

-0.509

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.355

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.791

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.139

UVUV-irradiationDNAdamaging

1.120

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.148

Antimycin12.5-50 ug/mL Antimycin A?

-0.451

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.205

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.251

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.964

PA8240.2-2 ug/mL PA-824?

0.193

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.116

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.129

Verapamil50 uM Verapamil?

0.037

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.046

methoxatin10-20 ug/mL Methoxatin?